Effects of chronic nicotine and haloperidol administration on muscarinic receptor-mediated phosphoinositide turnover in rat brain slices

Psychopharmacology (Berl). 1992;109(1-2):248-50. doi: 10.1007/BF02245510.

Abstract

Muscarinic receptor-mediated phosphoinositide (PI) turnover in rat brain slices was assessed after chronic administration of nicotine (12 mg/kg/day) or haloperidol decanoate (1.5 mg/kg/day), either alone or in combination, for 6 weeks. Nicotine alone did not significantly alter carbachol-induced inositol monophosphate (IP1) accumulation in the frontal cortex, but did result in a significant increase in the hippocampus, and in a decrease in the striatum. Haloperidol alone attenuated carbachol-stimulated IP1 accumulation in all three brain regions. Chronic treatment with combined nicotine and haloperidol resulted in no significant change in carbachol-sensitive IP1 accumulation in either the frontal cortex or hippocampus but did result in a decrease in the striatum. The results suggest significant cross-talk between cholinergic and dopaminergic systems in affecting PI metabolism.

MeSH terms

  • Animals
  • Brain Chemistry / drug effects*
  • Carbachol / pharmacology
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism
  • Haloperidol / pharmacology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • In Vitro Techniques
  • Male
  • Neostriatum / drug effects
  • Neostriatum / metabolism
  • Nicotine / pharmacology*
  • Phosphatidylinositols / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Muscarinic / drug effects*

Substances

  • Phosphatidylinositols
  • Receptors, Muscarinic
  • Nicotine
  • Carbachol
  • Haloperidol